298 related articles for article (PubMed ID: 34363035)
1. XIAP gene therapy effects on retinal ganglion cell structure and function in a mouse model of glaucoma.
Visuvanathan S; Baker AN; Lagali PS; Coupland SG; Miller G; Hauswirth WW; Tsilfidis C
Gene Ther; 2022 Apr; 29(3-4):147-156. PubMed ID: 34363035
[TBL] [Abstract][Full Text] [Related]
2. Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure.
Yue J; Khan RS; Duong TT; Dine KE; Cui QN; O'Neill N; Aravand P; Liu T; Chaqour B; Shindler KS; Ross AG
Neurotherapeutics; 2023 Apr; 20(3):896-907. PubMed ID: 36941497
[TBL] [Abstract][Full Text] [Related]
3. Role of hypoxia-inducible factor-1α in preconditioning-induced protection of retinal ganglion cells in glaucoma.
Zhu Y; Zhang L; Gidday JM
Mol Vis; 2013; 19():2360-72. PubMed ID: 24319330
[TBL] [Abstract][Full Text] [Related]
4. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
[TBL] [Abstract][Full Text] [Related]
5. A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma.
Krishnan A; Kocab AJ; Zacks DN; Marshak-Rothstein A; Gregory-Ksander M
J Neuroinflammation; 2019 Sep; 16(1):184. PubMed ID: 31570110
[TBL] [Abstract][Full Text] [Related]
6. Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma.
Chiasseu M; Cueva Vargas JL; Destroismaisons L; Vande Velde C; Leclerc N; Di Polo A
J Neurosci; 2016 May; 36(21):5785-98. PubMed ID: 27225768
[TBL] [Abstract][Full Text] [Related]
7. AAV2-Mediated Expression of HspB1 in RGCs Prevents Somal Damage and Axonal Transport Deficits in a Mouse Model of Ocular Hypertension.
Nam MH; Nahomi RB; Pantcheva MB; Dhillon A; Chiodo VA; Smith WC; Nagaraj RH
Transl Vis Sci Technol; 2022 Nov; 11(11):8. PubMed ID: 36355386
[TBL] [Abstract][Full Text] [Related]
8. Effect of ocular hypertension on the pattern of retinal ganglion cell subtype loss in a mouse model of early-onset glaucoma.
Daniel S; Meyer KJ; Clark AF; Anderson MG; McDowell CM
Exp Eye Res; 2019 Aug; 185():107703. PubMed ID: 31211954
[TBL] [Abstract][Full Text] [Related]
9. Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma.
Nam MH; Stankowska DL; Johnson GA; Nahomi RB; Pantcheva MB; Nagaraj RH
Cell Death Dis; 2022 Nov; 13(11):958. PubMed ID: 36379926
[TBL] [Abstract][Full Text] [Related]
10. Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss.
Nuschke AC; Farrell SR; Levesque JM; Chauhan BC
Exp Eye Res; 2015 Dec; 141():111-24. PubMed ID: 26070986
[TBL] [Abstract][Full Text] [Related]
11. Comparison between axonal and retinal ganglion cell gene expression in various optic nerve injuries including glaucoma.
Levkovitch-Verbin H; Makarovsky D; Vander S
Mol Vis; 2013; 19():2526-41. PubMed ID: 24357921
[TBL] [Abstract][Full Text] [Related]
12. Increase in retinal ganglion cells' susceptibility to elevated intraocular pressure and impairment of their endogenous neuroprotective mechanism by age.
Levkovitch-Verbin H; Vander S; Makarovsky D; Lavinsky F
Mol Vis; 2013; 19():2011-22. PubMed ID: 24146536
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension.
Trost A; Motloch K; Bruckner D; Schroedl F; Bogner B; Kaser-Eichberger A; Runge C; Strohmaier C; Klein B; Aigner L; Reitsamer HA
Exp Eye Res; 2015 Jul; 136():59-71. PubMed ID: 26001526
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension.
Trost A; Motloch K; Koller A; Bruckner D; Runge C; Schroedl F; Bogner B; Kaser-Eichberger A; Strohmaier C; Ladek AM; Preishuber-Pfluegl J; Brunner SM; Aigner L; Reitsamer HA
Exp Eye Res; 2021 Dec; 213():108806. PubMed ID: 34715090
[TBL] [Abstract][Full Text] [Related]
15. TRPV4-induced Müller cell gliosis and TNF-α elevation-mediated retinal ganglion cell apoptosis in glaucomatous rats via JAK2/STAT3/NF-κB pathway.
Li Q; Cheng Y; Zhang S; Sun X; Wu J
J Neuroinflammation; 2021 Nov; 18(1):271. PubMed ID: 34789280
[TBL] [Abstract][Full Text] [Related]
16. JUN is important for ocular hypertension-induced retinal ganglion cell degeneration.
Syc-Mazurek SB; Fernandes KA; Libby RT
Cell Death Dis; 2017 Jul; 8(7):e2945. PubMed ID: 28726785
[TBL] [Abstract][Full Text] [Related]
17. NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function.
Fang F; Zhuang P; Feng X; Liu P; Liu D; Huang H; Li L; Chen W; Liu L; Sun Y; Jiang H; Ye J; Hu Y
Mol Ther; 2022 Apr; 30(4):1421-1431. PubMed ID: 35114390
[TBL] [Abstract][Full Text] [Related]
18. BCLX
Donahue RJ; Fehrman RL; Gustafson JR; Nickells RW
Cell Death Dis; 2021 Aug; 12(8):781. PubMed ID: 34376637
[TBL] [Abstract][Full Text] [Related]
19. S1PR1 signaling attenuates apoptosis of retinal ganglion cells via modulation of cJun/Bim cascade and Bad phosphorylation in a mouse model of glaucoma.
Basavarajappa D; Gupta V; Wall RV; Gupta V; Chitranshi N; Mirshahvaladi SSO; Palanivel V; You Y; Mirzaei M; Klistorner A; Graham SL
FASEB J; 2023 Jan; 37(1):e22710. PubMed ID: 36520045
[TBL] [Abstract][Full Text] [Related]
20. Regulated Cell Death of Retinal Ganglion Cells in Glaucoma: Molecular Insights and Therapeutic Potentials.
Zhao WJ; Fan CL; Hu XM; Ban XX; Wan H; He Y; Zhang Q; Xiong K
Cell Mol Neurobiol; 2023 Oct; 43(7):3161-3178. PubMed ID: 37338781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
